Hospital
ST Marys Medical Center
ST Marys Medical Center was paid $20.98M by Medicaid between Jan 2018 and Dec 2024, across 142 billing codes. Its largest line is 99285, emergency room visit (most serious) — 39% of everything it billed.
33Billing provider infoST MARYS MEDICAL CENTER
DULUTH, MN 55805
DULUTH, MN 55805
33aNPI1457393035assigned 06/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.98M
24GClaims409,590
24DCodes billed142
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Minnesota
Rank by total paid#14 of 36
Median peer was paid$11.46M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOREN, KEVIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,817 | $1.41M | |
| 2019 | 59,065 | $3.14M | |
| 2020 | 45,930 | $2.17M | |
| 2021 | 66,830 | $3.17M | |
| 2022 | 63,235 | $3.79M | |
| 2023 | 66,288 | $4.03M | |
| 2024incomplete | 46,425 | $3.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 39% | 51,119 | 44,735 | $8.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 52,160 | 44,684 | $6.79M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 31,633 | 27,650 | $2.57M |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 46,020 | 38,820 | $509K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.3% | 426 | 417 | $276K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 1,047 | 918 | $241K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 2,122 | 1,665 | $241K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,864 | 2,476 | $149K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,320 | 2,127 | $138K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,447 | 3,704 | $132K |
| 80053 | Comprehensive metabolic panel | <1% | 12,812 | 11,368 | $120K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,713 | 3,485 | $103K |
130 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,223 | $99K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,464 | $92K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,234 | $86K |
| G0378 | Hospital observation service, per hour | <1% | 1,752 | $85K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,559 | $84K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 691 | $81K |
| 93296 | <1% | 3,755 | $76K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 523 | $74K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,363 | $68K |
| 0002A | <1% | 1,770 | $54K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 7,976 | $53K |
| 0001A | <1% | 1,932 | $48K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 384 | $46K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,730 | $43K |
| 84484 | <1% | 4,617 | $32K | |
| 85027 | <1% | 6,765 | $28K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,288 | $24K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,266 | $24K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 311 | $23K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 135 | $22K |
| 82962 | <1% | 10,004 | $20K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 51 | $19K |
| 83605 | <1% | 2,842 | $18K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 268 | $18K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,390 | $17K |
| 83735 | <1% | 3,817 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 107 | $15K |
| 86140 | <1% | 3,228 | $13K | |
| 93017 | <1% | 357 | $12K | |
| A9270 | Non-covered item or service | <1% | 21,215 | $11K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 944 | $11K |
| 82077 | <1% | 2,113 | $10K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,155 | $9K |
| 84703 | <1% | 1,475 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 108 | $9K |
| 81001 | <1% | 2,266 | $8K | |
| 85610 | <1% | 3,394 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 250 | $7K |
| 83690 | <1% | 1,438 | $7K | |
| J2704 | Injection, propofol, 10 mg | <1% | 7,547 | $7K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 110 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,007 | $6K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 33 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 145 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 112 | $5K |
| 0012A | <1% | 142 | $4K | |
| G0400 | Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | <1% | 56 | $4K |
| 87632 | <1% | 61 | $4K | |
| 0011A | <1% | 142 | $4K | |
| 81003 | <1% | 902 | $4K | |
| 82248 | <1% | 1,290 | $3K | |
| 99152 | <1% | 718 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 181 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $2K |
| C1769 | Guide wire | <1% | 647 | $2K |
| 83880 | <1% | 123 | $2K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 64 | $2K |
| 99153 | Mod sedat endo service >5yrs | <1% | 290 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,163 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,059 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 6,500 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 5,534 | $2K |
| 84145 | <1% | 127 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 352 | $2K |
| 84132 | <1% | 891 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 610 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,478 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,334 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 62 | $1K |
| 96376 | <1% | 556 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 138 | $1K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 20 | $1K |
| 95806 | <1% | 26 | $1K | |
| 87040 | <1% | 237 | $1K | |
| 85379 | <1% | 100 | $1K | |
| 86900 | <1% | 357 | $1K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 300 | $1K |
| 86850 | <1% | 285 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,198 | $819.24 |
| 86901 | <1% | 357 | $770.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,286 | $689.05 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 172 | $678.80 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,489 | $654.71 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 40 | $598.55 |
| 0031A | <1% | 26 | $524.27 | |
| 80143 | <1% | 48 | $491.11 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,126 | $467.76 |
| 87077 | <1% | 125 | $448.46 | |
| 93226 | <1% | 53 | $418.64 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,228 | $353.53 |
| J3490 | Unclassified drugs | <1% | 487 | $345.66 |
| 85018 | <1% | 185 | $338.30 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 669 | $319.98 |
| 97161 | <1% | 13 | $244.64 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 75 | $229.06 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 106 | $219.33 |
| J1815 | Injection, insulin, per 5 units | <1% | 117 | $214.30 |
| 80179 | <1% | 20 | $208.98 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 47 | $207.37 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15 | $206.93 |
| 87186 | <1% | 72 | $202.05 | |
| 85730 | <1% | 29 | $135.18 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 367 | $122.74 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 104 | $118.28 |
| 82565 | <1% | 49 | $116.56 | |
| 88342 | <1% | 55 | $112.64 | |
| 76937 | <1% | 35 | $93.42 | |
| Q3014 | Telehealth originating site facility fee | <1% | 66 | $79.95 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 46 | $75.00 |
| 84702 | <1% | 12 | $66.64 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 17 | $56.25 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 121 | $52.80 |
| 87070 | <1% | 14 | $43.79 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 42 | $35.20 |
| 87205 | <1% | 16 | $26.10 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 58 | $17.60 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 57 | $17.15 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 16 | $6.76 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 1,305 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 16 | $0.00 |
| 91300 | 0% | 410 | $0.00 | |
| 88173 | 0% | 24 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 16 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 17 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 14 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 14 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 15 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 73 | $0.00 |
| 88341 | 0% | 52 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOREN, KEVIN (VP OF FINANCE)
Parent organizationESSENTIA HEALTH
| Provider | Location | Paid |
|---|---|---|
| The Duluth Clinic, LTD | Duluth, MN | $51.60M |
| ST. Joseph's Medical Center | Brainerd, MN | $41.35M |
| SMDC Medical Center | Duluth, MN | $35.51M |
| ST. Mary's Hospital of Superior | Superior, WI | $13.36M |
| ST Joseph's Medical Center | Baxter, MN | $7.23M |
| ST. Mary's Duluth Clinic Health System | Duluth, MN | $4.97M |
| Deer River Healthcare Center, INC. | Deer River, MN | $4.57M |
| ST. Mary's Medical Center | Duluth, MN | $3.66M |
| ST. Joseph's Medical Center | Brainerd, MN | $3.25M |
| The Duluth Clinic, LTD | Virginia, MN | $2.82M |
| The Duluth Clinic, LTD | Duluth, MN | $2.66M |
| Northern Pines Medical Center | Aurora, MN | $1.72M |
| ST. Mary's Hospital of Superior | Superior, WI | $1.65M |
| Polinsky Medical Rehabilitation Center | Duluth, MN | $1.61M |
| Pine Medical Center | Sandstone, MN | $1.32M |
| The Duluth Clinic, LTD | Hermantown, MN | $1.30M |
| The Duluth Clinic LTD | Grand Rapids, MN | $1.18M |
| The Duluth Clinic, LTD | Duluth, MN | $1.13M |
| The Duluth Clinic, LTD | Ashland, WI | $1.07M |
| ST Mary's Hospital of Superior | Spooner, WI | $1.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.